Humanigen signs manufacturing deal with Emergent for experimental COVID-19 drug
Shares of Humanigen Inc. were down 2.5% in trading on Monday after it announced a contract development and manufacturing deal with Emergent BioSolutions Inc. for its experimental COVID-19.....»»
Johnson & Johnson takes over COVID-19 vaccine production at Baltimore plant after 15 million doses were ruined
Johnson & Johnson said it was "assuming full responsibility regarding the manufacturing of drug substance" at Emergent B.....»»
Merck signs $356 million deal with U.S. government for experimental COVID-19 therapy
Shares of Merck & Co. Inc. gained 0.4% in premarket trading on Wednesday after the drugmaker said.....»»
J&J to pay Emergent $135 million as part of COVID-19 vaccine manufacturing deal
Shares of Johnson & Johnson were up 0.4% in premarket trading on Friday after the company announced a.....»»
FDA says data for CytoDyn"s experimental COVID-19 therapy does not demonstrate a clinical benefit
Shares of CytoDyn Inc. were up 0.5% in trading on Tuesday, the day after the Food and Drug Administration issued a statement saying "it has become clear" that the clinical-tri.....»»
Humanigen and Chime Biologics in manufacturing pact for lenzilumab for Covid
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Humanigen Shares Gain On FDA Emergency Filing Plans For COVID-19 Drug By June
Humanigen Inc (NASDAQ: HGEN) is prepping its COVID-19 drug lenzilumab for an emergency use authorization with the FDA before the month’s end. According to its Q1 financial report out Thursday after-ho.....»»
Moderna enters deal with Sanofi for COVID-19 vaccine fill/ finish manufacturing
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA inspection of Emergent"s COVID-19 vaccine plant identifies "potential quality issues"
Shares of Emergent BioSolutions Inc. were up 1.3% in trading on Wednesday after the Food and Drug Administration said it inspected a plant in Baltimore that had been scheduled to begin producing Johnson & Johnson's COVID-19.....»»
Emergent says experimental COVID-19 treatment failed in Phase 3 trial
Emergent BioSolutions Inc. said Fr.....»»
Humanigen skyrockets 107% after results show its drug candidate improves COVID-19 survival in patients without a ventilator
The company anno.....»»
: Vir Biotechnology shares surge after COVID-19 antibody drug shown to reduce risk of death
Shares of Vir Biotechnology surged 30% in early trading on Thursday, after the company said its experimental COVID-19 treatment, being developed with GlaxoSmithKline, significantly reduced hospitalization and death in high-risk adults......»»
: Vir surges 50% after COVID-19 antibody drug shown to reduce risk of death
Shares of Vir Biotechnology surged 35% in premarket trading on Thursday, after the company said its experimental COVID-19 treatment, being developed with GlaxoSmithKline, significantly reduced hospitalization and death in high-risk adults......»»
GSK to refocus study of experimental COVID-19 antibody treatment on patients 70 and older
Shares of GlaxoSmithKline were down 0.2% in trading on Thursday after the drug maker said its experimental monoclonal antibody treatment did not meet the primary endpoint in a mid-stage trial evaluating its use in hospitalized COVID-19 patients of all a.....»»
The supply of COVID-19 vaccines in the US is about to get a big boost, according to drug makers
Pfizer and Moderna have improved manufacturing capabilities and plan to deliver doses to the US ahead of schedule. Dado Ruvic/Reuters Dado Ruvic/Reut.....»»
: J&J’s one-shot COVID-19 vaccine nears authorization as FDA has no ‘specific safety concerns’
The Food and Drug Administration said that Johnson & Johnson's single-dose COVID-19 vaccine candidate has no unexpected safety concerns, in a step that moves the experimental vaccine one step closer to emergency authorization......»»
FDA committee to review J&J"s COVID-19 vaccine candidate this week
A Food and Drug Administration advisory committee is set to meet Friday to vote on whether the regulator should authorize Johnson & Johnson's experimental single-dose.....»»
FDA committee to review J&J"s COVID-19 vaccine candidate on Thursday
A Food and Drug Administration advisory committee is set to meet Thursday to vote on whether the regulator should authorize Johnson & Johnson's experimental single-d.....»»
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 19) read more.....»»
Novavax enters into new agreement for 1.1B Covid vaccine doses
Novavax Inc. is working toward a deal with a global health partnership to provide 1.1 billion doses of its experimental Covid-19 vaccine. The Gaithersburg company said Thursday it has entered into a memorandum of understanding with Gavi, the Vaccine Al.....»»
Humanigen and Ajinomoto Bio-Pharma Services expand manufacturing pact for Covid
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»